Literature DB >> 8766198

Are cytokines responsible for the asthmatic state of the airways?

J C Kips1, R A Pauwels.   

Abstract

Chronic mucosal airway inflammation is currently considered to be the central element in the pathophysiology of asthma. This inflammatory process is regulated by a complex network of mutually interacting cytokines. The overall pattern of cytokine expression in asthma is one of increased expression of T-helper 2-like cytokines, including interleukin (IL)-4 and IL-5, in addition to proinflammatory cytokines, such as tumour necrosis factor-alpha (TNF-alpha) and IL-1 beta. The precise functional importance of each of these cytokines within the global network remains to be fully established. This question has been addressed in a number of in vivo animal studies. Combining these data with descriptive findings in man makes it possible to address somewhat further the question of the in vivo significance of a specific cytokine in the asthmatic state of the airways. This paper reviews some of the data currently available on this subject.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8766198

Source DB:  PubMed          Journal:  Monaldi Arch Chest Dis        ISSN: 1122-0643


  3 in total

1.  Functional characterization and biomarker identification in the Brown Norway model of allergic airway inflammation.

Authors:  Stephen L Underwood; El-Bdaoui Haddad; Mark A Birrell; Kerryn McCluskie; Michaela Pecoraro; Dominika Dabrowski; Stephen E Webber; Martyn L Foster; Maria G Belvisi
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739

2.  Effect of a matrix metalloproteinase-12 inhibitor, S-1, on allergic airway disease phenotypes in mice.

Authors:  Yingyan Yu; Yoshihiko Chiba; Hiroyasu Sakai; Miwa Misawa
Journal:  Inflamm Res       Date:  2010-01-12       Impact factor: 4.575

3.  Interleukin-1beta mediates human airway epithelial cell migration via NF-kappaB.

Authors:  Steven R White; Bernard M Fischer; Bertha A Marroquin; Randi Stern
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-10-10       Impact factor: 5.464

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.